Delivery Order SPE2DB24D1021-SPE2DB25FETBA
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,981.53 firm fixed-price delivery order contract covers the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, with a period of performance through December 30, 2024.
AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,853.61 firm fixed-price delivery order is for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024.
The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award is a delivery order valued at $4,124.64 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for REXULTI 1 MG TABLET 30S, a specialty medication, with a period of performance through December 24, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REXULTI 2 MG TABLET 30S. The firm-fixed-price contract has a ceiling value of $31,839.50 and a period of performance through November 5, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
This federal contract award, valued at $25,573.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of January 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $24,866.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total ceiling value of $999,999,999 and runs through November 2026.
The contract is for the delivery of REXULTI 4 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs globally....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $21,964.62 fixed-price delivery order is for the supply of REXULTI 2 MG TABLET 30S, a medication used in the treatment of mental health conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of REXULTI 0.5 MG TABLET 30S. The $2,740.41 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,891.25 delivery order contract is for the supply of REXULTI 3 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025 and is a firm fixed-price delivery order. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, valued at $1,951.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a completion date of January 3, 2025. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...